Acute Heartburn Treatment
For immediate relief of acute heartburn, use antacids as first-line therapy, as they provide the fastest symptom relief within 10 minutes by neutralizing acid already in the esophagus 1, 2.
Immediate Treatment Algorithm
For Single Episode or Occasional Heartburn:
- Antacids are the most rapidly acting agents for acute symptom relief 1
- Antacid hydrotalcite provides significantly faster relief than H2-receptor antagonists (H2RAs), with symptom reduction beginning within 10 minutes and superior efficacy maintained for the first 3 hours 2
- Antacids can be combined with an H2RA or PPI to sustain efficacy beyond the initial rapid relief 1
For On-Demand Treatment (Patients with Recurrent Episodes):
When rapid onset is the priority, the treatment hierarchy is:
- Antacids - fastest onset (within 10 minutes)
- H2RAs - onset within 30 minutes, lasting up to 12 hours 3
- PPIs - require several days to reach maximum effect, not ideal for acute episodes 1
Important Caveats
Avoid metoclopramide - it is specifically recommended against (Grade D) for GERD syndromes as monotherapy or adjunctive therapy 1.
When Antacids Alone Are Insufficient:
If the patient requires treatment beyond a single acute episode:
- For short-course therapy: PPIs are more effective than H2RAs, which are more effective than placebo (Grade B recommendation) 1
- For frequent heartburn (≥2 days per week): PPIs are superior to antacids and H2RAs 4
- H2RAs develop tolerance with repeat dosing, limiting their utility for frequent symptoms 4
Dosing Considerations for Escalation:
If empirical PPI therapy is initiated:
- Start with once-daily dosing
- If inadequate response, escalate to twice-daily PPI dosing before considering treatment failure 1
- Patients not responding to twice-daily PPI therapy should be considered treatment failures and require endoscopic evaluation 1
Emerging Options
Potassium-competitive acid blockers (P-CABs) like vonoprazan show rapid onset with benefit appearing as early as day 1 5, but given current costs and lack of superiority data over standard PPIs for uncomplicated heartburn, they should generally not be used as first-line therapy (2024 AGA guidance) 6. They may be considered in selected patients who fail twice-daily PPI therapy 6.
Practical Approach
For the patient presenting with acute heartburn right now: Give antacids immediately. If they have a pattern of recurrent episodes requiring on-demand treatment, prescribe H2RAs for episodes with 30-minute advance notice (before meals that trigger symptoms). Reserve PPIs for patients with frequent symptoms requiring daily preventive therapy rather than acute treatment.